Alcon Inc (ALC)
88.83
-0.23
(-0.26%)
USD |
NYSE |
May 17, 16:00
88.83
0.00 (0.00%)
After-Hours: 20:00
Alcon Shareholders Equity (Quarterly): 20.83B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 20.83B |
| December 31, 2023 | 20.62B |
| December 31, 2022 | 19.68B |
| September 30, 2022 | 19.65B |
| June 30, 2022 | 19.54B |
| March 31, 2022 | 19.49B |
| December 31, 2021 | 19.26B |
| September 30, 2021 | 19.09B |
| Date | Value |
|---|---|
| June 30, 2021 | 19.06B |
| March 31, 2021 | 18.91B |
| December 31, 2020 | 18.82B |
| September 30, 2020 | 18.66B |
| June 30, 2020 | 18.77B |
| March 31, 2020 | 19.17B |
| December 31, 2019 | 19.30B |
| December 31, 2018 | 22.64B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
18.66B
Minimum
Sep 2020
20.83B
Maximum
Mar 2024
19.39B
Average
19.26B
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| Novartis AG | 39.68B |
| AC Immune SA | 160.35M |
| CRISPR Therapeutics AG | 2.084B |
| Addex Therapeutics Ltd | 1.364M |
| NLS Pharmaceutics Ltd | -4.287M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.56B |
| Total Liabilities (Quarterly) | 8.738B |
| Debt to Equity Ratio | 0.2252 |
| Current Ratio | 2.512 |
| Net Debt Paydown Yield | -0.03% |